Apolinario Arantxa, Majano Pedro L, Alvarez-Pérez Eduardo, Saez Alicia, Lozano Carlos, Vargas Javier, García-Monzón Carmelo
Hepatology Unit, University Hospital Santa Cristina, Madrid, Spain.
Am J Gastroenterol. 2002 Nov;97(11):2861-70. doi: 10.1111/j.1572-0241.2002.07054.x.
Although chemokines seem to be important in certain inflammatory disorders, little is known about the role of these proteins in chronic hepatitis C.
Expression of selected CXC and CC chemokines and their receptors was assessed by immunohistochemistry and flow cytometry in chronic hepatitis C. Tissue samples from normal liver and that of sustained responders were also evaluated. A comparative analysis between the histological grading and the intrahepatic expression level of chemokines was performed.
The majority of liver-derived T lymphocytes expressed CXCR3 and CCR5 chemokine receptors, representing high enrichment over levels of CXCR3 + and CCR5 + T cells in blood from chronic hepatitis C. An intense intrahepatic expression of their respective ligands, the CXC chemokine Mig, and RANTES, was detected in the same patients studied, being restricted to the sinusoidal endothelium and to hepatocytes, respectively. A statistically significant association between the intrahepatic chemokine expression level and the inflammatory activity of chronic hepatitis C was found. Of note was the marked expression of both CXCR3 and its ligand Mig on endothelial cells from portal neovessels in chronic hepatitis C.
Intrahepatic chemokine signaling could play a key role regulating significant pathological events during chronic hepatitis C, opening new avenues for therapeutic interventions based on chemokine activities.
尽管趋化因子在某些炎症性疾病中似乎很重要,但对于这些蛋白质在慢性丙型肝炎中的作用却知之甚少。
通过免疫组织化学和流式细胞术评估慢性丙型肝炎中选定的CXC和CC趋化因子及其受体的表达。还对正常肝脏和持续应答者的组织样本进行了评估。对趋化因子的组织学分级和肝内表达水平进行了比较分析。
大多数肝源性T淋巴细胞表达CXCR3和CCR5趋化因子受体,与慢性丙型肝炎患者血液中CXCR3+和CCR5+T细胞水平相比有高度富集。在同一研究患者中检测到其各自配体CXC趋化因子Mig和RANTES在肝内的强烈表达,分别局限于窦状内皮细胞和肝细胞。发现肝内趋化因子表达水平与慢性丙型肝炎的炎症活性之间存在统计学上的显著关联。值得注意的是,在慢性丙型肝炎门静脉新生血管的内皮细胞上CXCR3及其配体Mig均有明显表达。
肝内趋化因子信号传导可能在调节慢性丙型肝炎期间的重大病理事件中起关键作用,为基于趋化因子活性的治疗干预开辟了新途径。